A Study of ZW251 in Participants With Advanced Solid Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Maggie Weinstein, MD, PhD, MPH
Zymeworks BC Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Start - Dublin Mater Misericordiae University Hospital (mmuh)
Dublin, Ireland
Austin Duffy, MD, DMedRecruiting
- National Cancer Center East
Kashiwa, Japan
Masafumi Ikeda, MD, PhDRecruiting - Kyoto University Hospital
Kyoto, Japan
Takako Nakajima, MDRecruiting - Kansai Medical University Hospital
Osaka, Japan
Toshio Shimizu, MD, PhDRecruiting - National Cancer Center Hospital
Tokyo, Japan
Yuta Maruki, MDRecruiting
- Start Lisboa A - Unidade de Ensaios Clãnicos - Hospital de Santa Maria
Lisbon, Portugal
Andre Mansinho, MD, MScRecruiting - Unidade Local de Saúde Gaia E Espinho
Vila Nova de Gaia, Portugal
Andreia Capela, MDRecruiting
- Hospital Universitario Vall D'Hebron
Barcelona, Spain
Jaume Capdevila Castillon, MD, PhDRecruiting - Start Barcelona
Barcelona, Spain
Tatiana Hernandez Guerrero, MD, PhDRecruiting - Start - Rioja Hospital Universitario San Pedro
Logroño, Spain
Maria Jose de Miguel Luken, MDRecruiting - Next Oncology Madrid
Madrid, Spain
Valentina Boni, MD, PhDRecruiting - Start Madrid Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
Manuel Pedregal Trujillo, MDRecruiting - Start Madrid Hospital Universitario Hm Sanchinarro - Ciocc
Madrid, Spain
Emiliano Calvo, MD, PhDRecruiting - Hospital Universitario Virgen de la Victoria
Málaga, Spain
Javier Garcia Corbacho, MDRecruiting - Clinica Universidad de Navarra
Pamplona, Spain
Bruno Sangro, MD, PhDRecruiting
- National Taiwan University Hospital
Taipei, Taiwan
Ann Lii Cheng, MDRecruiting - Taipei Veterans General Hospital
Taipei, Taiwan
Yi-Hsiang Huang, MD, PhDRecruiting
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
Katie Kelley, MDRecruiting - University of California Los Angeles - Cancer Care - Santa Monica (ucla)
Santa Monica, California, United States
Richard Finn, MDRecruiting - Norton Cancer Institute
Louisville, Kentucky, United States
John Hamm, MD FACP, FASCORecruiting - Start Midwest
Grand Rapids, Michigan, United States
Sreenivasa Chandana, MD, PhDRecruiting - Hackensack University Medical Center
Hackensack, New Jersey, United States
Martin Gutierrez, MDRecruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Ghassan Abou-Alfa, MD, JD, MBA, PhDRecruiting - Md Anderson Cancer Center
Houston, Texas, United States
Ecaterina Dumbrava, MDRecruiting - Start San Antonio
San Antonio, Texas, United States
Muralidhar Beeram, MD, MBBSRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Oct 2025
- Primary completion
- 30 Sept 2027
- Completion
- 31 May 2028
- Last update posted
- 7 May 2026
- Registered enrollment
- 100
- Registry id
- NCT07164313
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.